Histogen Stock Buy Hold or Sell Recommendation
| HSTO Stock | USD 0.02 0.01 25.65% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Histogen is 'Strong Sell'. The recommendation algorithm takes into account all of Histogen's available fundamental, technical, and predictive indicators you will find on this site.
Check out Histogen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide. In addition, we conduct extensive research on individual companies such as Histogen and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Histogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Histogen |
Execute Histogen Buy or Sell Advice
The Histogen recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Histogen. Macroaxis does not own or have any residual interests in Histogen or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Histogen's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Histogen Trading Alerts and Improvement Suggestions
| Histogen generated a negative expected return over the last 90 days | |
| Histogen has high historical volatility and very poor performance | |
| Histogen has some characteristics of a very speculative penny stock | |
| Histogen has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 19 K. Net Loss for the year was (12.38 M) with loss before overhead, payroll, taxes, and interest of (1.25 M). | |
| Histogen currently holds about 12.6 M in cash with (10.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Histogen has a frail financial position based on the latest SEC disclosures |
Histogen Returns Distribution Density
The distribution of Histogen's historical returns is an attempt to chart the uncertainty of Histogen's future price movements. The chart of the probability distribution of Histogen daily returns describes the distribution of returns around its average expected value. We use Histogen price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Histogen returns is essential to provide solid investment advice for Histogen.
| Mean Return | -1.42 | Value At Risk | -4.55 | Potential Upside | 4.76 | Standard Deviation | 13.17 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Histogen historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Histogen Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Histogen, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading Histogen back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
| Shares | Highlander Capital Management Llc | 2024-03-31 | 17.0 |
Histogen Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (962K) | 4.7M | 12.3M | (6.6M) | (10.1M) | (9.6M) | |
| Free Cash Flow | (1.4M) | (12.1M) | (14.8M) | (9.9M) | (10.1M) | (10.6M) | |
| Depreciation | 145K | 98K | 97K | 140K | 138K | 144.9K | |
| Other Non Cash Items | 1.8M | 7.1M | (450K) | 61K | 54.9K | 52.2K | |
| Capital Expenditures | 66K | 152K | 49K | 241K | 216K | 0.0 | |
| Net Income | (3.0M) | (18.8M) | (15.0M) | (10.6M) | (12.4M) | (13.0M) | |
| End Period Cash Flow | 2.1M | 6.8M | 19.1M | 12.5M | 4.9M | 4.6M | |
| Net Borrowings | (479K) | (32K) | 459K | (9K) | (10.4K) | (10.9K) | |
| Change To Netincome | 2.0M | 7.9M | 195K | 540K | 621K | 590.0K |
Histogen Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Histogen or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Histogen's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Histogen stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1.29 | |
β | Beta against Dow Jones | -1.23 | |
σ | Overall volatility | 13.48 | |
Ir | Information ratio | -0.12 |
Histogen Volatility Alert
Histogen is displaying above-average volatility over the selected time horizon. Histogen is a penny stock. Although Histogen may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Histogen. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Histogen instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Histogen Fundamentals Vs Peers
Comparing Histogen's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Histogen's direct or indirect competition across all of the common fundamentals between Histogen and the related equities. This way, we can detect undervalued stocks with similar characteristics as Histogen or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Histogen's fundamental indicators could also be used in its relative valuation, which is a method of valuing Histogen by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Histogen to competition |
| Fundamentals | Histogen | Peer Average |
| Return On Equity | -1.2 | -0.31 |
| Return On Asset | -0.54 | -0.14 |
| Operating Margin | (705.00) % | (5.51) % |
| Current Valuation | (4.49 M) | 16.62 B |
| Shares Outstanding | 4.27 M | 571.82 M |
| Shares Owned By Insiders | 2.85 % | 10.09 % |
| Number Of Shares Shorted | 67.03 K | 4.71 M |
| Price To Book | 0.02 X | 9.51 X |
| Price To Sales | 4.50 X | 11.42 X |
| Revenue | 19 K | 9.43 B |
| Gross Profit | (1.25 M) | 27.38 B |
| EBITDA | (11.92 M) | 3.9 B |
| Net Income | (12.38 M) | 570.98 M |
| Cash And Equivalents | 12.6 M | 2.7 B |
| Cash Per Share | 5.04 X | 5.01 X |
| Total Debt | 4.63 M | 5.32 B |
| Debt To Equity | 0.31 % | 48.70 % |
| Current Ratio | 13.22 X | 2.16 X |
| Book Value Per Share | 1.27 X | 1.93 K |
| Cash Flow From Operations | (10.07 M) | 971.22 M |
| Short Ratio | 4.25 X | 4.00 X |
| Earnings Per Share | (2.81) X | 3.12 X |
| Price To Earnings To Growth | (0.04) X | 4.89 X |
| Target Price | 2.0 | |
| Number Of Employees | 7 | 18.84 K |
| Beta | 1.12 | -0.15 |
| Market Capitalization | 85.44 K | 19.03 B |
| Total Asset | 19.07 M | 29.47 B |
| Retained Earnings | (88.27 M) | 9.33 B |
| Working Capital | 12.22 M | 1.48 B |
| Net Asset | 19.07 M |
Note: Acquisition by Spada Alfred P of 313436 shares of Histogen subject to Rule 16b-3 [view details]
Histogen Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Histogen . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.2 | |||
| Daily Balance Of Power | (1.35) | |||
| Rate Of Daily Change | 0.74 | |||
| Day Median Price | 0.0226 | |||
| Day Typical Price | 0.0217 | |||
| Market Facilitation Index | 0.0051 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
About Histogen Buy or Sell Advice
When is the right time to buy or sell Histogen? Buying financial instruments such as Histogen Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Histogen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Monster Funds Thematic Idea Now
Monster Funds
Solid funds with above average long term performance indicators based on Macroaxis rating system. The Monster Funds theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Monster Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Histogen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Histogen. If investors know Histogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Histogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.81) | Revenue Per Share 0.004 | Return On Assets (0.54) | Return On Equity (1.20) |
The market value of Histogen is measured differently than its book value, which is the value of Histogen that is recorded on the company's balance sheet. Investors also form their own opinion of Histogen's value that differs from its market value or its book value, called intrinsic value, which is Histogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Histogen's market value can be influenced by many factors that don't directly affect Histogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Histogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Histogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Histogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.